282 related articles for article (PubMed ID: 30666202)
21. Regional and Cellular Mapping of Sortilin Immunoreactivity in Adult Human Brain.
Xu SY; Zhang QL; Zhang Q; Wan L; Jiang J; Tu T; Manavis J; Pan A; Cai Y; Yan XX
Front Neuroanat; 2019; 13():31. PubMed ID: 30914927
[TBL] [Abstract][Full Text] [Related]
22. Y682G Mutation of Amyloid Precursor Protein Promotes Endo-Lysosomal Dysfunction by Disrupting APP-SorLA Interaction.
La Rosa LR; Perrone L; Nielsen MS; Calissano P; Andersen OM; Matrone C
Front Cell Neurosci; 2015; 9():109. PubMed ID: 25904844
[TBL] [Abstract][Full Text] [Related]
23. Sortilin in Glucose Homeostasis: From Accessory Protein to Key Player?
Blondeau N; Béraud-Dufour S; Lebrun P; Hivelin C; Coppola T
Front Pharmacol; 2018; 9():1561. PubMed ID: 30697159
[TBL] [Abstract][Full Text] [Related]
24. SorLA modulates atheroprotective properties of CLA by regulating monocyte migration.
McCarthy C; O'Gaora P; James WG; de Gaetano M; McClelland S; Fitzgerald DJ; Belton O
Atherosclerosis; 2010 Dec; 213(2):400-7. PubMed ID: 20970138
[TBL] [Abstract][Full Text] [Related]
25. Protein sorting gone wrong--VPS10P domain receptors in cardiovascular and metabolic diseases.
Schmidt V; Willnow TE
Atherosclerosis; 2016 Feb; 245():194-9. PubMed ID: 26724530
[TBL] [Abstract][Full Text] [Related]
26. Development of a Cell-Based Assay to Assess Binding of the proNGF Prodomain to Sortilin.
Malik I; Christensen S; Stavenhagen JB; Dietz GPH
Cell Mol Neurobiol; 2018 May; 38(4):827-840. PubMed ID: 29067536
[TBL] [Abstract][Full Text] [Related]
27. SorLA deficiency dissects amyloid pathology from tau and cholinergic neurodegeneration in a mouse model of Alzheimer's disease.
Capsoni S; Carlo AS; Vignone D; Amato G; Criscuolo C; Willnow TE; Cattaneo A
J Alzheimers Dis; 2013; 33(2):357-71. PubMed ID: 22986780
[TBL] [Abstract][Full Text] [Related]
28. Highly segregated localization of the functionally related vps10p receptors sortilin and SorCS2 during neurodevelopment.
Boggild S; Molgaard S; Glerup S; Nyengaard JR
J Comp Neurol; 2018 Jun; 526(8):1267-1286. PubMed ID: 29405286
[TBL] [Abstract][Full Text] [Related]
29. SorLA in Interleukin-6 Signaling and Turnover.
Larsen JV; Petersen CM
Mol Cell Biol; 2017 Jun; 37(11):. PubMed ID: 28265003
[TBL] [Abstract][Full Text] [Related]
30. Identification of the first small-molecule ligand of the neuronal receptor sortilin and structure determination of the receptor-ligand complex.
Andersen JL; Schrøder TJ; Christensen S; Strandbygård D; Pallesen LT; García-Alai MM; Lindberg S; Langgård M; Eskildsen JC; David L; Tagmose L; Simonsen KB; Maltas PJ; Rønn LC; de Jong IE; Malik IJ; Egebjerg J; Karlsson JJ; Uppalanchi S; Sakumudi DR; Eradi P; Watson SP; Thirup S
Acta Crystallogr D Biol Crystallogr; 2014 Feb; 70(Pt 2):451-60. PubMed ID: 24531479
[TBL] [Abstract][Full Text] [Related]
31. Sortilin-related receptor CNS expressed 2 (SorCS2) is localized to Bunina bodies in amyotrophic lateral sclerosis.
Mori F; Miki Y; Tanji K; Kakita A; Takahashi H; Utsumi J; Sasaki H; Wakabayashi K
Neurosci Lett; 2015 Nov; 608():6-11. PubMed ID: 26420026
[TBL] [Abstract][Full Text] [Related]
32. The multifaceted role of sortilin/neurotensin receptor 3 in human cancer development.
Ghaemimanesh F; Mehravar M; Milani S; Poursani EM; Saliminejad K
J Cell Physiol; 2021 Sep; 236(9):6271-6281. PubMed ID: 33634506
[TBL] [Abstract][Full Text] [Related]
33. SORLA attenuates EphA4 signaling and amyloid β-induced neurodegeneration.
Huang TY; Zhao Y; Jiang LL; Li X; Liu Y; Sun Y; Piña-Crespo JC; Zhu B; Masliah E; Willnow TE; Pasquale EB; Xu H
J Exp Med; 2017 Dec; 214(12):3669-3685. PubMed ID: 29114064
[TBL] [Abstract][Full Text] [Related]
34. VPS10P-domain receptors - regulators of neuronal viability and function.
Willnow TE; Petersen CM; Nykjaer A
Nat Rev Neurosci; 2008 Dec; 9(12):899-909. PubMed ID: 19002190
[TBL] [Abstract][Full Text] [Related]
35. Focal Adhesion Kinase-Dependent Role of the Soluble Form of Neurotensin Receptor-3/Sortilin in Colorectal Cancer Cell Dissociation.
Béraud-Dufour S; Devader C; Massa F; Roulot M; Coppola T; Mazella J
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834811
[TBL] [Abstract][Full Text] [Related]
36. The sorLA cytoplasmic domain interacts with GGA1 and -2 and defines minimum requirements for GGA binding.
Jacobsen L; Madsen P; Nielsen MS; Geraerts WP; Gliemann J; Smit AB; Petersen CM
FEBS Lett; 2002 Jan; 511(1-3):155-8. PubMed ID: 11821067
[TBL] [Abstract][Full Text] [Related]
37. Characterization of the VPS10 domain of SorLA/LR11 as binding site for the neuropeptide HA.
Lintzel J; Franke I; Riedel IB; Schaller HC; Hampe W
Biol Chem; 2002 Nov; 383(11):1727-33. PubMed ID: 12530537
[TBL] [Abstract][Full Text] [Related]
38. SorLA regulates the activity of lipoprotein lipase by intracellular trafficking.
Klinger SC; Glerup S; Raarup MK; Mari MC; Nyegaard M; Koster G; Prabakaran T; Nilsson SK; Kjaergaard MM; Bakke O; Nykjær A; Olivecrona G; Petersen CM; Nielsen MS
J Cell Sci; 2011 Apr; 124(Pt 7):1095-105. PubMed ID: 21385844
[TBL] [Abstract][Full Text] [Related]
39. Internally tagged Vps10p-domain receptors reveal uptake of the neurotrophin BDNF.
Klein M; Failla AV; Hermey G
J Biol Chem; 2023 Oct; 299(10):105216. PubMed ID: 37660918
[TBL] [Abstract][Full Text] [Related]
40. The mosaic receptor sorLA/LR11 binds components of the plasminogen-activating system and platelet-derived growth factor-BB similarly to LRP1 (low-density lipoprotein receptor-related protein), but mediates slow internalization of bound ligand.
Gliemann J; Hermey G; Nykjaer A; Petersen CM; Jacobsen C; Andreasen PA
Biochem J; 2004 Jul; 381(Pt 1):203-12. PubMed ID: 15053742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
